OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
16.00
-0.39 (-2.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
OnKure Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OnKure Therapeutics stock have an average target of 37.5, with a low estimate of 35 and a high estimate of 40. The average target predicts an increase of 134.38% from the current stock price of 16.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OKUR stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 |
---|---|
Strong Buy | 1 |
Buy | 1 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +150.00% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +150.00% | Oct 17, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +118.75% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.